Pharmacology in Pediatric Renal Solid Organ Transplantation.
AI interpretation is pending for this paper.
Open original publication →What the AI sees
Not AI summarized yet.
Research significance
Pending deeper interpretation.
Source abstract
In pediatric renal transplantation, managing immunosuppression is critical to prevent graft rejection while also reducing the risks of infection, cancer, and medication side effects. This review covers both induction and maintenance immunosuppression agents. Pediatric patients face unique challenges due to their continuous growth and development, requiring careful dosing adjustments and comprehensive education for both patients and caregivers. Collaboration among multidisciplinary professionals is essential to enhance patient outcomes and ensure long-term graft survival in this particularly at-risk population.